SLNO · Soleno Therapeutics Inc

$53.01 +0.00 (+0.00%) At close · May 18

Market Cap

$2.76B

52.12M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Anish Bhatnagar	CEO	$640,000	—	$46,883,000	$3,231,230	$403,200	$3,000	$51,160,430
James H. MacKaness	CFO	$460,000	—	$6,923,200	$1,195,555	$193,200	$3,000	$8,774,955
Meredith Manning	Chief Commercial Officer	$415,179	—	$1,947,200	$5,234,010	$173,661	$13,000	$7,783,050
Patricia Hirano	Senior Vice President of Regulatory Affairs	$375,000	—	$5,018,600	$516,997	$137,813	$3,000	$6,051,410

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Anish Bhatnagar	CEO	$556,800	$500,000	$843,161	$2,216,473	—	—	$4,116,434
James H. MacKaness	CFO	$400,000	$240,000	$152,691	$418,945	—	—	$1,211,636
Patricia Hirano	Senior Vice President of Regulatory Affairs	$340,000	$153,000	$147,782	$388,190	—	—	$1,028,973

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Anish Bhatnagar	CEO	$556,800	$278,400	—	$293,492	—	—	$1,128,692
James H. MacKaness	CFO	$385,000	$154,000	—	$87,195	—	—	$626,195
Patricia Hirano	Senior Vice President of Regulatory Affairs	$326,000	$97,800	—	$53,134	—	—	$476,934

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Anish Bhatnagar	CEO	$538,000	$80,700	—	$3,756,742	—	—	$4,375,442
Patricia Hirano	Senior Vice President of Regulatory Affairs	$315,000	$28,350	—	$577,476	—	—	$920,826
Kristen Yen	Senior Vice President of Global Clinical Operations and Patient Advocacy	$291,000	$26,190	—	$504,476	—	—	$821,666

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Anish Bhatnagar	CEO	$504,000	$252,000	$1,466,850	$684,250	—	—	$2,907,100
Patricia Hirano	Senior Vice President of Regulatory Affairs	$300,000	$75,000	$448,525	$68,425	—	—	$891,950
James H. MacKaness	CFO	$198,988	—	$38,500	$472,980	—	—	$710,468

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Anish Bhatnagar	CEO	$470,000	$82,250	—	$269,839	—	—	$822,089
Patricia Hirano	Senior Vice President of Regulatory Affairs	$260,208	$24,500	—	$71,237	—	—	$355,946
Kristen Yen	Senior Vice President of Global Clinical Operations and Patient Advocacy	$250,000	$21,875	—	$64,761	—	—	$336,636

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Anish Bhatnagar	CEO	$460,000	$80,500	—	$411,411	—	—	$951,911
Kristen Yen	Senior Vice President of Global Clinical Operations and Patient Advocacy	$235,000	$20,560	—	$77,139	—	—	$332,699

Executive changes

Person	Role	Change	Effective	Filed
James Mackaness	Chief Financial Officer	Retired	—	2026-02-26
Jennifer Fulk	Chief Financial Officer	Appointed	2026-03-02	2026-02-26

Key facts CIK 1484565 CUSIP 834203309 Visit website Investor relations